Mouse Model
Mouse Model are used in the study 'Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.' (Li H et al., 2009), Mouse Model are used in the study 'Lysophosphatidic acid signaling may initiate fetal hydrocephalus.' (Yung YC et al., 2011), Mouse Model are used in the study 'LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.' (Sakai N et al., 2013), Mouse Model are used in the study 'Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.' (Su SC et al., 2013) and Mouse Model are used in the study 'NHERF2 is necessary for basal activity, second messenger inhibition, and LPA stimulation of NHE3 in mouse distal ileum.' (Murtazina R et al., 2011).
Knock-out
Knock-out are used in the study 'Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA1 receptor.' (Urs NM et al., 2008), Knock-out are used in the study 'Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase.' (Liu S et al., 2004), Knock-out are used in the study 'Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.' (Li H et al., 2005), Knock-out are used in the study 'Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.' (van Meeteren LA et al., 2006) and Knock-out are used in the study 'Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.' (Hama K et al., 2004).
Xenograft Model
Xenograft Model are used in the study 'Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.' (Su SC et al., 2013), Xenograft Model are used in the study 'Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.' (Chen H et al., 2010), Xenograft Model are used in the study 'Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.' (Zhang H et al., 2009) and Xenograft Model are used in the study 'Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.' (Mukherjee A et al., 2012).
Related references are published most in these journals:
Model |
Cross reference |
Weighted score |
Related literatures |
Loading... please refresh the page if content is not showing up.